MOLECULE: AMG 424*
CLINICAL TRIALS:
Study title Phase Status
Study Evaluating AMG 424 in Subjects With Multiple MyelomaPhase 1Recruiting

*XmAb® bispecific antibody developed in collaboration with Xencor